Sobi with new haemophilia research office in Greece

Swedish Orphan Biovitrum (Sobi) will open a new office in Athens, Greece. 

“The opening in Greece supports our efforts in meeting the needs for treatment for rare disease patients all over Europe”, says Hege Hellström, President Sobi EMENAR.

The ribbon cutting ceremony in Aegli Zappeiou will happen today and attendance of  Paschalis Apostolides, President of the Hellenic Association of Pharmaceutical Companies (SFEE) and Dimitris Verykios, Vice President of the Greek Haemophilia Society as well as Hege Hellström, President Sobi EMENAR, Sergio Lai, General Manager Sobi, Italy, Greece, Cyprus and Malta and Nicola Zancan, Market Development Director Sobi, Greece, Cyprus and Malta, the company said in its press release.

“Our Athens office will enable expanding access to innovative treatments and we aim through close dialogue and cooperation with the Greek authorities to provide high quality care and sustainable access to treatment for people living with rare diseases in Greece”, says Sergio Lai, General Manager Sobi, Italy, Greece, Cyprus and Malta.

“The Greek Hemophilia Society welcomes Sobi to Greece and hopes that its presence in our country will contribute to providing high quality products and sustainable access to therapeutic treatments for people with haemophilia and other inherited bleeding disorders”, says Dimitris Verykios, Vice President of the Greek Hemophilia Society.